Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WAEBER B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baechtold, F; Scott, JA; Markert, M; Mehta, S; McCormack, DG; Anglada, F; Galaud, D; Vaglio, M; Waeber, B; Feihl, F
      Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?

      SHOCK
    2. O'Brien, E; Waeber, B; Parati, G; Staessen, J; Myers, MG
      Blood pressure measuring devices: recommendations of the European Society of Hypertension

      BRITISH MEDICAL JOURNAL
    3. Waeber, B
      Treatment strategy to control blood pressure optimally in hypertensive patients

      BLOOD PRESSURE
    4. Waeber, B
      Achieving blood pressure targets in the management of hypertension

      BLOOD PRESSURE
    5. Sieg-Dobrescu, D; Burnier, M; Hayoz, D; Brunner, HR; Waeber, B
      The return of increased blood pressure after discontinuation of anti hypertensive treatment is associated with an impaired post-ischemic skin blood flow response

      JOURNAL OF HYPERTENSION
    6. Waeber, B; Aschwanden, R; Sadecky, L; Ferber, P
      Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

      JOURNAL OF HYPERTENSION
    7. Waeber, B; Brunner, HR
      The multifactorial nature of hypertension: the greatest challenge for its treatment?

      JOURNAL OF HYPERTENSION
    8. Haefliger, JA; Demotz, S; Braissant, O; Suter, E; Waeber, B; Nicod, P; Meda, P
      Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension

      KIDNEY INTERNATIONAL
    9. Baechtold, F; Cavadas, C; Gasser, D; Markert, M; Grouzmann, E; Peterson, KL; Waeber, B; Feihl, F
      Cardiovascular effects of fentanyl in conscious rats

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    10. Waeber, B
      A review of irbesartan in anti hypertensive therapy: Comparison with otheranti hypertensive agents

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    11. Kubli, S; Feihl, F; Waeber, B
      Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    12. Waeber, B
      Blood pressure control: a review on irbesartan

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    13. Denolle, T; Waeber, B; Kjeldsen, S; Parati, G; Wilson, M; Asmar, R
      Self-measurement of blood pressure in clinical trials and therapeutic applications

      BLOOD PRESSURE MONITORING
    14. Waeber, B
      Proceedings from a Workshop on Measurement of Blood Pressure of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension, Milan, June 1999

      BLOOD PRESSURE MONITORING
    15. Kubli, S; Waeber, B; Dalle-Ave, A; Feihl, F
      Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    16. Waeber, B; Burnier, M; Brunner, HR
      How to improve adherence with prescribed treatment in hypertensive patients?

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    17. Waeber, B
      New recommendations for the treatment of hypertension: A theoretical concept or a useful tool in practice?

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    18. Waeber, B; Brunner, HR
      Clinical applications and limitations in the use of AT(1) receptor antagonists

      DRUGS, ENZYMES AND RECEPTORS OF THE RENIN-ANGIOTENSIN SYSTEM: CELEBRATING A CENTURY OF DISCOVERY
    19. Waeber, B; Vetter, W; Darioli, R; Keller, U; Brunner, HR
      Improved blood pressure control by monitoring compliance with antihypertensive therapy

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    20. Waeber, B; Burnier, M; Brunner, HR
      Compliance with antihypertensive therapy

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    21. Waeber, B; Detry, JM; Dahlof, B; Puig, JG; Gundersen, T; Hosie, J; Januszewicz, W; Lindstrom, CJ; Magometschnigg, D; Safar, M; Tanser, P; Toutouzas, P
      Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?

      AMERICAN JOURNAL OF HYPERTENSION
    22. Waeber, B; Leonetti, G; Kolloch, R; McInnes, GT
      Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study

      JOURNAL OF HYPERTENSION
    23. Haefliger, JA; Waeber, B; Grouzmann, E; Braissant, O; Nussberger, J; Nicod, P; Waeber, G
      Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats

      REGULATORY PEPTIDES
    24. Schwed, A; Fallab, CL; Burnier, M; Waeber, B; Kappenberger, L; Burnand, B; Darioli, R
      Electronic monitoring of compliance to lipid-lowering therapy in clinical practice

      JOURNAL OF CLINICAL PHARMACOLOGY
    25. Waeber, B; Burnier, M; Brunner, HR
      Comment on the treatment of arterial hypertension

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    26. Waeber, B; Brunner, HR
      A look through the new therapeutic window: irbesartan

      JOURNAL OF HYPERTENSION
    27. HANSSON L; ZANCHETTI A; WAEBER B
      THE HYPERTENSION OPTIMAL STUDY

      Zhongguo yaoli xuebao
    28. AUBERT L; BOVET P; GERVASONI JP; RWEBOGORA A; WAEBER B; PACCAUD F
      KNOWLEDGE, ATTITUDES, AND PRACTICES ON HYPERTENSION IN A COUNTRY IN EPIDEMIOLOGIC TRANSITION

      Hypertension
    29. RUTSCHMANN B; EVEQUOZ D; AUBERT JF; BRUNNER HR; WAEBER B
      VASOPRESSIN DILATES THE RAT CAROTID-ARTERY BY STIMULATING V1 RECEPTORS

      Journal of cardiovascular pharmacology
    30. WAEBER B
      THE PLACE OF ACE-INHIBITION IN THE MODERN THERAPEUTIC ERA - BEYOND BLOOD-PRESSURE CONTROL - INTRODUCTION

      Journal of cardiovascular pharmacology
    31. WAEBER B
      NORMALIZING ARTERIAL BLOOD-PRESSURE IN TH E HYPERTENSIVE PATIENT - MISSION IMPOSSIBLE

      Schweizerische medizinische Wochenschrift
    32. WAEBER B; PRATT CM
      T-CHANNEL BLOCKADE - A NEW ADVANCE IN THE TREATMENT OF CARDIOVASCULAR-DISEASES - INTRODUCTION

      Cardiology
    33. WAEBER B
      POTENTIAL CARDIOPROTECTIVE EFFECT OF MIBEFRADIL IN THE LONG-TERM TREATMENT OF HYPERTENSION

      Cardiology
    34. WAEBER B; BRUNNER HR
      COMBINATION ANTIHYPERTENSIVE THERAPY - DOES IT HAVE A ROLE IN RATIONAL THERAPY

      American journal of hypertension
    35. WAEBER B; BRUNNER HR
      LOW-DOSE COMBINATIONS VERSUS MONOTHERAPIES IN THE TREATMENT OF HYPERTENSION

      Journal of hypertension
    36. HAGMANN M; NUSSBERGER J; NAUDIN RB; BURNS TS; KARIM A; WAEBER B; BRUNNER HR
      SC-52458, AN ORALLY-ACTIVE ANGIOTENSIN II-RECEPTOR ANTAGONIST - INHIBITION OF BLOOD-PRESSURE RESPONSE TO ANGIOTENSIN-II CHALLENGES AND PHARMACOKINETICS IN NORMAL VOLUNTEERS

      Journal of cardiovascular pharmacology
    37. FAVRE O; DELACRETAZ E; BADAN M; GLAUSER M; WAEBER B
      RELATIONSHIP BETWEEN THE PRESCRIBERS INSTRUCTIONS AND COMPLIANCE WITHANTIBIOTHERAPY IN OUTPATIENTS TREATED FOR AN ACUTE INFECTIOUS-DISEASE

      Journal of clinical pharmacology
    38. SCHWED A; DARIOLI R; FALLAB CL; KAPPENBERGER L; BURNIER B; WAEBER B
      PATTERNS OF NON COMPLIANCE TO CHOLESTEROL-LOWERING THERAPY ASSESSED BY ELECTRONIC MONITORING

      Atherosclerosis
    39. HAEFLIGER JA; CASTILLO E; WAEBER G; BERGONZELLI GE; AUBERT JF; SUTTER E; NICOD P; WAEBER B; MEDA P
      HYPERTENSION INCREASES CONNEXIN43 IN A TISSUE-SPECIFIC MANNER

      Circulation
    40. WAEBER B; BRUNNER HR
      MEASURING THE BLOOD-PRESSURE - THE BEST WAY TO ASSESS CARDIOVASCULAR RISK

      Archives des maladies du coeur et des vaisseaux
    41. KATZ E; NICOD P; BRUNNER HR; WAEBER B
      CHANGES IN TREATMENT DURING AND AFTER HOSPITALIZATION IN PATIENTS TAKING DRUGS FOR CARDIOVASCULAR-DISEASES

      Cardiovascular drugs and therapy
    42. WAEBER B; WEIDMANN P; WOHLER D; BLOCH YL
      ALBUMINURIA IN DIABETES-MELLITUS - RELATION TO AMBULATORY VERSUS OFFICE BLOOD-PRESSURE AND EFFECTS OF CILAZAPRIL

      American journal of hypertension
    43. WAEBER B; BRUNNER HR
      ANGIOTENSIN-II ANTAGONISTS - A SPECIAL TH ERAPEUTIC CLASS

      La Presse medicale
    44. WAEBER B; BURNIER M; NUSSBERGER J; BRUNNER HR
      EXPERIENCE WITH ANGIOTENSIN-II ANTAGONISTS IN HYPERTENSIVE PATIENTS

      Clinical and experimental pharmacology and physiology
    45. BIDLINGMEYER I; BURNIER M; BIDLINGMEYER M; WAEBER B; BRUNNER HR
      ISOLATED OFFICE HYPERTENSION - A PREHYPERTENSIVE STATE

      Journal of hypertension
    46. BRUNNER HR; WAEBER B
      DO WE NEED NEW ANTIHYPERTENSIVE DRUGS

      Journal of cardiovascular pharmacology
    47. WAEBER B; BRUNNER HR
      CARDIOVASCULAR HYPERTROPHY - ROLE OF ANGIOTENSIN-II AND BRADYKININ

      Journal of cardiovascular pharmacology
    48. BURNIER M; BUCLIN T; BIOLLAZ J; NUSSBERGER J; WAEBER B; BRUNNER HR
      PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF 3 ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN NORMAL VOLUNTEERS

      Kidney international
    49. WAEBER B; BRUNNER HR
      AMBULATORY BLOOD-PRESSURE MONITORING IN T HE DIAGNOSIS OF HYPERTENSIVE PATIENTS

      Schweizerische medizinische Wochenschrift
    50. EVEQUOZ D; AUBERT JF; NUSSBERGER J; BIOLLAZ J; DIEZI J; BRUNNER HR; WAEBER B
      EFFECTS OF NEUROPEPTIDE-Y ON INTRARENAL HEMODYNAMICS, PLASMA RENIN ACTIVITY AND URINARY SODIUM-EXCRETION IN RATS

      Nephron
    51. LAZOR R; FEIHL F; WAEBER B; KUCERA P; PERRET C
      ENDOTHELIN-1 DOES NOT MEDIATE THE ENDOTHELIUM-DEPENDENT HYPOXIC CONTRACTIONS OF SMALL PULMONARY-ARTERIES IN RATS

      Chest
    52. LACROIX JS; RICCHETTI AP; MOREL D; MOSSIMANN B; WAEBER B; GROUZMANN E
      INTRANASAL ADMINISTRATION OF NEUROPEPTIDE-Y IN MAN - SYSTEMIC ABSORPTION AND FUNCTIONAL-EFFECTS

      British Journal of Pharmacology
    53. WAEBER B; BRUNNER HR
      ANGIOTENSIN-II ANTAGONISTS - A NEW CLASS OF ANTIHYPERTENSIVE AGENT

      British journal of clinical practice
    54. WAEBER B; BURNIER M
      RENIN SECRETION - THE DIFFICULTY OF EXTRAPOLATING FROM IN-VITRO TO IN-VIVO STUDIES

      European journal of endocrinology
    55. ZANCHI A; SCHAAD NC; OSTERHELD MC; GROUZMANN E; NUSSBERGER J; BRUNNER HR; WAEBER B
      EFFECTS OF CHRONIC NO SYNTHASE INHIBITION IN RATS ON RENIN-ANGIOTENSIN SYSTEM AND SYMPATHETIC NERVOUS-SYSTEM

      American journal of physiology. Heart and circulatory physiology
    56. BURNIER M; PECHEREBERTSCHI A; NUSSBERGER J; WAEBER B; BRUNNER HR
      STUDIES OF THE RENAL EFFECTS OF ANGIOTENSIN-II RECEPTOR BLOCKADE - THE CONFOUNDING FACTOR OF ACUTE WATER LOADING ON THE ACTION OF VASOACTIVE SYSTEMS

      American journal of kidney diseases
    57. FAVRAT B; BURNIER M; NUSSBERGER J; LECOMTE JM; BROUARD R; WAEBER B; BRUNNER HR
      NEUTRAL ENDOPEPTIDASE VERSUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITIONIN ESSENTIAL-HYPERTENSION

      Journal of hypertension
    58. NIEDERBERGER M; AUBERT JF; NUSSBERGER J; BRUNNER HR; WAEBER B
      SYMPATHETIC-NERVE ACTIVITY IN CONSCIOUS RENAL HYPERTENSIVE RATS TREATED WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR AN ANGIOTENSIN-II ANTAGONIST

      Journal of hypertension
    59. BRUNNER HR; WAEBER B; BURNIER M
      RENAL HEMODYNAMIC AND PROTECTIVE EFFECTS OF CALCIUM-ANTAGONISTS IN HYPERTENSION

      Journal of hypertension
    60. ZANCHI A; DELACRETAZ E; TALEB V; GAILLARD R; JEANRENAUD B; BRUNNER HR; WAEBER B
      ENDOTHELIAL FUNCTION OF THE MESENTERIC ARTERIOLE AND MECHANICAL-BEHAVIOR OF THE CAROTID-ARTERY IN RATS WITH INSULIN-RESISTANCE AND HYPERCHOLESTEROLEMIA

      Journal of hypertension
    61. WAEBER B; BRUNNER HR
      MAIN OBJECTIVES AND NEW ASPECTS OF COMBINATION TREATMENT OF HYPERTENSION

      Journal of hypertension
    62. BURNIER M; WAEBER B; BRUNNER HR
      CLINICAL-PHARMACOLOGY OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN POTASSIUM IN HEALTHY-SUBJECTS

      Journal of hypertension
    63. STAESSEN JA; FAGARD R; THIJS L; AMERY A; CELLS H; VANHOOF R; ASMAR R; BUNTINX F; DECORT P; CLEMENT D; DUPREZ D; COATS AJS; CONWAY J; DEGAUTE JP; DEPLAEN JF; DELEEUW PW; DEVEREUX RB; PICKERING TG; EFSTRATOPOULOS AD; ELLIOTT HL; GELLERT J; GOSSE P; IMAI Y; IMHOLZ BPM; VANMONTFRANS GA; WESSELING KH; KINGSWOOD C; LIU LS; MALLION JM; OBRIEN ET; OCONPUJADAS K; OTSUKA K; PALATINI P; PARATI G; PERLOFF D; PORCELLATI C; VERDECCHIA P; RAFTERY EB; REDON J; ROSENFELD J; RYNKIEWICZ A; SALVETTI A; TUOMILHETO J; VANHANEN H; WAEBER B; WHITE WB; WEBSTER J
      A CONSENSUS VIEW ON THE TECHNIQUE OF AMBULATORY BLOOD-PRESSURE MONITORING

      Hypertension
    64. HAEFLIGER JA; BERGONZELLI G; WAEBER G; AUBERT JF; NUSSBERGER J; GAVRAS H; NICOD P; WAEBER B
      RENIN AND ANGIOTENSIN-II RECEPTOR GENE-EXPRESSION IN KIDNEYS OF RENALHYPERTENSIVE RATS

      Hypertension
    65. HAYOZ D; WEBER R; RUTSCHMANN B; DARIOLI R; BURNIER M; WAEBER B; BRUNNER HR
      POSTISCHEMIC BLOOD-FLOW RESPONSE IN HYPERCHOLESTEROLEMIC PATIENTS

      Hypertension
    66. DELACRETAZ E; ZANCHI A; NUSSBERGER J; HAYOZ D; AUBERT JF; BRUNNER HR; WAEBER B
      CHRONIC NITRIC-OXIDE SYNTHASE INHIBITION AND CAROTID-ARTERY DISTENSIBILITY IN RENAL HYPERTENSIVE RATS

      Hypertension
    67. BURNIER M; HAGMAN M; NUSSBERGER J; BIOLLAZ J; ARMAGNAC C; BROUARD R; WAEBER B; BRUNNER HR
      SHORT-TERM AND SUSTAINED RENAL EFFECTS OF ANGIOTENSIN-II RECEPTOR BLOCKADE IN HEALTHY-SUBJECTS

      Hypertension
    68. BOVET P; HUNGERBUHLER P; QUILINDO J; GRETTVE ML; WAEBER B; BURNAND B
      SYSTEMATIC DIFFERENCE BETWEEN BLOOD-PRESSURE READINGS CAUSED BY CUFF TYPE (VOL 24, PG 786, 1994)

      Hypertension
    69. DELACRETAZ E; NUSSBERGER J; BIOLLAZ J; WAEBER B; BRUNNER HR
      CHARACTERIZATION OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST TCN-116 INHEALTHY-VOLUNTEERS

      Hypertension
    70. EVEQUOZ D; GROUZMANN E; NUSSBERGER J; NIEDERBERGER M; BRUNNER HR; WAEBER B
      BETA-ADRENOCEPTOR STIMULATION INCREASES NEUROPEPTIDE-Y RELEASE FROM SYMPATHETIC-NERVES IN INTACT RATS

      Regulatory peptides
    71. DELACRETAZ E; DEQUAY N; WAEBER B; VIAL Y; SCHULZ PE; BURNIER M; BRUNNER HR; BOSSART H; SCHAAD NC
      DIFFERENTIAL NITRIC-OXIDE SYNTHASE ACTIVITY IN HUMAN PLATELETS DURINGNORMAL-PREGNANCY AND PREECLAMPSIA

      Clinical science
    72. HUNGERBUHLER P; BOVET P; SHAMLAYE C; BURNAND B; WAEBER B
      COMPLIANCE WITH MEDICATION AMONG OUTPATIENTS WITH UNCONTROLLED HYPERTENSION IN THE SEYCHELLES

      Bulletin of the World Health Organization
    73. BURNIER M; WAEBER B; BRUNNER HR
      DIAGNOSIS AND TREATMENT OF HYPERTENSIVE E MERGENCIES

      Schweizerische medizinische Wochenschrift
    74. ZANCHI A; AUBERT JF; BRUNNER HR; WAEBER B
      VASCULAR ACETYLCHOLINE RESPONSE DURING CHRONIC NO SYNTHASE INHIBITION- IN-VIVO VERSUS IN-VITRO

      Cardiovascular Research
    75. WAEBER B; WEBER R; BRUNNER HR
      PHYSIOPATHOLOGY OF LEFT-VENTRICULAR HYPER TROPHY

      Archives des maladies du coeur et des vaisseaux
    76. BURNIER M; FAVRAT B; NUSSBERGER J; LECOMTE JM; WAEBER B; BRUNNER HR
      NEUTRAL ENDOPEPTIDASE (NEP) VERSUS ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITION IN HYPERTENSION - RESULTS OF A DOUBLE-BLIND CROSS-OVER STUDY COMPARING SINORPHAN TO CAPTOPRIL

      Journal of the American Society of Nephrology
    77. BIDLINGMEYER M; KAESER P; PERRET F; DARIOLI R; WAEBER B; BRUNNER HR; BURNIER M
      EFFECT OF SIMVASTATIN ON SERUM-CHOLESTEROL AND PLATELET FREE CALCIUM IN NONOBESE, NONHYPERTENSIVE PATIENTS WITH HYPERLIPOPROTEINEMIA

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    78. WAEBER B; BRUNNER HR
      CALCIUM DEFICIENCY IN THE ELDERLY - A FACTOR CONTRIBUTING TO THE DEVELOPMENT OF HYPERTENSION

      European journal of endocrinology
    79. EVEQUOZ D; BURNIER M; NIEDERBERGER M; BRUNNER HR; NUSSBERGER J; WAEBER B
      MECHANISMS OF THE PRESSOR-RESPONSE TO INTRAVENOUS THYROTROPIN-RELEASING-HORMONE IN THE RAT

      Clinical and experimental pharmacology and physiology
    80. BRUNNER HR; DELACRETAZ E; NUSSBERGER J; BURNIER M; WAEBER B
      ANGIOTENSIN-II ANTAGONISTS DUP-753 AND TCV-116

      Journal of hypertension
    81. WAEBER B; ERNE P; SAXENHOFER H; HEYNEN G
      USE OF DRUGS WITH MORE THAN A TWENTY-4-HOUR DURATION OF ACTION

      Journal of hypertension
    82. BURNIER M; WAEBER B; BRUNNER HR
      THE ADVANTAGES OF ANGIOTENSIN-II ANTAGONISM

      Journal of hypertension
    83. GROUZMANN E; ALVAREZBOLADO G; MEYER C; OSTERHELD MC; BURNIER M; BRUNNER HR; WAEBER B
      LOCALIZATION OF NEUROPEPTIDE-Y AND ITS C-TERMINAL FLANKING PEPTIDE INHUMAN RENAL TISSUE

      Peptides
    84. BRUNNER HR; NUSSBERGER J; WAEBER B
      DOSE-RESPONSE RELATIONSHIPS OF ACE-INHIBITORS AND ANGIOTENSIN-II BLOCKERS

      European heart journal
    85. BOVET P; HUNGERBUHLER P; QUILINDO J; GRETTVE ML; WAEBER B; BURNAND B
      SYSTEMATIC DIFFERENCE BETWEEN BLOOD-PRESSURE READINGS CAUSED BY CUFF TYPE

      Hypertension
    86. DELACRETAZ E; HAYOZ D; OSTERHELD MC; GENTON CY; BRUNNER HR; WAEBER B
      LONG-TERM NITRIC-OXIDE SYNTHASE INHIBITION AND DISTENSIBILITY OF CAROTID-ARTERY IN INTACT RATS

      Hypertension
    87. GROUZMANN E; CRESSIER F; WALKER P; HOFBAUER K; WAEBER B; BRUNNER HR
      INTERACTIONS BETWEEN NPY AND ITS RECEPTOR - ASSESSMENT USING ANTI-NPYANTIBODIES

      Regulatory peptides
    88. ZELIS R; NUSSBERGER J; CLEMSON B; WAEBER B; GROUZMANN E; BRUNNER HR
      NEUROPEPTIDE-Y INFUSION DECREASES PLASMA-RENIN ACTIVITY IN POSTMYOCARDIAL INFARCTION RATS

      Journal of cardiovascular pharmacology
    89. DELACRETAZ E; NUSSBERGER J; PUCHLER K; WOOD AJ; ROBINSON PR; WAEBER B; BRUNNER HR
      VALUE OF DIFFERENT CLINICAL AND BIOCHEMICAL CORRELATES TO ASSESS ANGIOTENSIN-CONVERTING ENZYME-INHIBITION

      Journal of cardiovascular pharmacology
    90. GROUZMANN E; WERFFELIGEORGE P; FATHI M; BURNIER M; WAEBER B; WAEBER G
      ANGIOTENSIN-II MEDIATES NOREPINEPHRINE AND NEUROPEPTIDE-Y SECRETION IN A HUMAN PHEOCHROMOCYTOMA

      The Journal of clinical endocrinology and metabolism
    91. EVEQUOZ D; GROUZMANN E; BECKSICKINGER AG; BRUNNER HR; WAEBER B
      DIFFERENTIAL VASCULAR EFFECTS OF NEUROPEPTIDE-Y (NPY) SELECTIVE RECEPTOR AGONISTS

      Experientia
    92. EVEQUOZ D; GROUZMANN E; BRUNNER HR; WAEBER B; ERNE P
      THE INCREASE IN PLASMA NEUROPEPTIDE-Y CONCENTRATION INDUCED BY EXERCISE IS BLUNTED IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC CORONARY-ARTERY DISEASE

      Circulation
    93. EVEQUOZ D; GROUZMANN E; BRUNNER HR; WAEBER B; ERNE P
      THE INCREASE IN PLASMA NEUROPEPTIDE-Y CONCENTRATION INDUCED BY EXERCISE IS BLUNTED IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC CORONARY-ARTERY DISEASE

      Circulation
    94. BRUNNER HR; NUSSBERGER J; BURNIER M; WAEBER B
      ANGIOTENSIN-II ANTAGONISTS

      Clinical and experimental hypertension
    95. WAEBER B; BRUNNER HR
      AMBULATORY BLOOD-PRESSURE MONITORING TO ASSESS ANTIHYPERTENSIVE THERAPY IN PRIVATE-PRACTICE

      Journal of human hypertension
    96. WOHLER D; WAEBER B; LUSCHER TF; SCHUBIGER JL; BRUNNER HR
      AMBULATORY BLOOD-PRESSURE MONITORING IN C LINICAL-PRACTICE SUPPLIES IMPORTANT INFORMATION COMPLEMENTARY TO OFFICE BLOOD-PRESSURE

      Nieren- und Hochdruckkrankheiten
    97. BRUNNER HR; NUSSBERGER J; WAEBER B
      ANGIOTENSIN-II BLOCKADE COMPARED WITH OTHER PHARMACOLOGICAL METHODS OF INHIBITING THE RENIN-ANGIOTENSIN SYSTEM

      Journal of hypertension
    98. BRUNNER HR; NUSSBERGER J; WAEBER B
      CONTROL OF VASCULAR TONE BY RENIN AND ANGIOTENSIN IN CARDIOVASCULAR-DISEASE

      European heart journal
    99. BURNIER M; RUTSCHMANN B; NUSSBERGER J; VERSAGGI J; SHAHINFAR S; WAEBER B; BRUNNER HR
      SALT-DEPENDENT RENAL EFFECTS OF AN ANGIOTENSIN-II ANTAGONIST IN HEALTHY-SUBJECTS

      Hypertension
    100. DELACRETAZ E; HAYOZ D; GENTON C; BRUNNER HR; WAEBER B
      EFFECT OF CHRONIC NO SYNTHASE INHIBITION ON THE DISTENSIBILITY OF THECAROTID-ARTERY IN INTACT RATS

      Hypertension


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/08/20 alle ore 07:51:13